RxDoctor Payments Data

Jonathan Epstein, MD

Anatomic Pathology & Clinical Pathology · Baltimore, MDNPI 1093749574

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,156 of the $32,744 with a category attached, or 89.0%. 5 manufacturers reported payments, led by Merck at 57.4% of the total. Reporting peaked in 2020 at $19,736 and has fallen 99.9% since, to $28 in 2025. Among anatomic pathology & clinical pathology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,744in general payments, 2019–2025

Across 10 payments — averaging $3274.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$19K
  • Urogen Pharma, Inc.$7K
  • Roche Diagnostics Corporation$4K
  • AstraZeneca$2K
  • E.r. Squibb & Sons, L.L.C.$930
$17,750in research payments, 2019–2025

Across 2 payments — averaging $8875.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Urogen Pharma, Inc.$18K

What the payments were for

  • Consulting fees$29,15689%
  • Speaking & faculty fees$3,56011%
  • Food & beverage$280%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,744 in reported general payments places this provider in the 95th percentile of 186 anatomic pathology & clinical pathology providers in Maryland.

See all anatomic pathology & clinical pathology providers in Maryland

Medicare billing

Part B allowed, 2024
$1,077,010
Medicare patients
2,910
Services billed
4,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →